Nasal Vaccines Market is Anticipated to Witness High Growth Owing to Increasing Preference for Non-Invasive Mode of Administration

 

Nasal Vaccines Market

Nasal vaccines, also known as intranasal vaccines, are administered through the nose to elicit immune response at the site of infection. These vaccines produce both systemic and mucosal immunity by stimulating antibody production in the nose as well as the rest of the body. Nasal vaccines offer several advantages over injectable vaccines such as ease of self-administration, elimination of sharps waste, needle stick injuries, and lower cold storage requirements. They can also induce protective immunity against respiratory pathogens within a few days of administration. The global nasal vaccines market is driven by the rising need for thermostable and non-invasive vaccination methods especially during pandemics. Increasing preference for vaccines that are needle-free and provide first-line defense against respiratory infections is also fueling market growth.


The Global nasal vaccines market is estimated to be valued at US$ 480.16 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Global Nasal Vaccines Market Demand are Fresenius SE & Co. KgaA, Glenmark Pharmaceuticals, Carlsbad Tech, GlaxoSmithKline PLC, Zydus Cadila, Epi Health LLC, Viatris Inc., Apotex Inc., Teva Pharmaceuticals Industries Ltd., and Emcure Pharmaceuticals Ltd (Avet Pharmaceuticals Inc.), among others. These players are focusing on developing thermostable nasal vaccines to facilitate distribution in low and middle-income countries.

The market is witnessing several opportunities for innovation in development of new delivery platforms, adjuvants, and nasal formulations of existing vaccines. Advancements in vector technologies, such as live attenuated viral vectors and bacterial vectors are enabling development of more efficacious nasal vaccines.

Major players are expanding globally to increase access to nasal vaccines. For instance, GlaxoSmithKline expanded manufacturing of its flu vaccine FluMist in China. Additionally, partnerships with governments and international organizations are helping drive large clinical trials and global availability of nasal vaccines.

Market Drivers
Growing prevalence of respiratory infections worldwide due to changing demographics, pollution, and climate change is driving the demand for preventive nasal vaccines. According to WHO, respiratory diseases caused over 4 million deaths in 2019.

Increasing R&D investments by government and private entities to develop thermostable nasal vaccines is expected to fuel market growth. For example, the US government funded over $16 million from 2014-2019 in development of stable nasal vaccines.

Market Restrains
Complex nasal anatomy and physiology hinders effective delivery and immune response to certain nasal vaccine formulations. Further research is required to understand nasal absorption mechanisms.

High costs associated with clinical development and production of nasal vaccines as compared to injectable vaccines restrains market growth. Setting up large scale manufacturing units for nasal vaccines requires sizable investments.

Segment Analysis
The Nasal Vaccines Market is dominated by Live-Attenuated Vaccines which accounted for around 55% share in 2020. Live-attenuated vaccines provide longer-lasting and broader protection compared to subunit or killed vaccines. The antigens produced from live-attenuated vaccines closely resemble the natural occurring infections which stimulate both systemic and mucosal immune responses. This helps in quicker response against the pathogens. Subunit & killed vaccines segment is expected to witness highest growth during the forecast period owing to rising adoption of these vaccines for influenza immunization.

Global Analysis
Regionally, North America is expected to dominate the Nasal Vaccines Market during the forecast period. This is attributed to presence of major players, high awareness about disease prevention, and supportive vaccination programs in the region. Europe is anticipated to be the second-most-lucrative market due to increasing burden of chronic respiratory diseases. However, Asia Pacific is projected to register highest growth rate owning to large patient pool, improving healthcare infrastructure, and rising government funding for immunization in developing countries such as India and China. The market in Latin America and Middle East & Africa is still at nascent stage.

Get more insights on this topic: Nasal Vaccines Market

Explore More Articles: Bulk SMS Marketing Services Market

Comments

Post a Comment

Popular posts from this blog

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv...
Read more